Martin L. Kabongo
Publications by Year
Research Areas
Influenza Virus Research Studies, Respiratory viral infections research, SARS-CoV-2 and COVID-19 Research, Immune Response and Inflammation, Complementary and Alternative Medicine Studies
Most-Cited Works
- → Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin(2010)141 cited
- The use of complementary and alternative medicine by primary care patients. A SURF*NET study.(2000)
- → Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40–70 years of age(2013)122 cited
- The Use of Complementary and Alternative Medicine by Primary Care Patients(2000)
- → Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans(2013)67 cited
- → A Single Dose of Unadjuvanted Novel 2009 H1N1 Vaccine Is Immunogenic and Well Tolerated in Young and Elderly Adults(2010)41 cited
- Necrotizing fasciitis: a diagnostic challenge.(1997)
- → Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose(2018)27 cited
- Analysis of 583 Physician-Reported Errors(2009)